Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemo-proteomics exploration of HDAC degradability by small molecule degraders
Yuan Xiong, Katherine A. Donovan, Nicholas A. Eleuteri, et al.
Cell chemical biology (2021) Vol. 28, Iss. 10, pp. 1514-1527.e4
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Target and tissue selectivity of PROTAC degraders
Robert G. Guenette, Seung Wook Yang, Jaeki Min, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 14, pp. 5740-5756
Closed Access | Times Cited: 152
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 101
Targeting histone deacetylases for cancer therapy: Trends and challenges
Liang Tao, Fengli Wang, Reham M. Elhassan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2425-2463
Open Access | Times Cited: 94
UM171 glues asymmetric CRL3–HDAC1/2 assembly to degrade CoREST corepressors
Megan J. R. Yeo, Olivia Zhang, Xiaowen Xie, et al.
Nature (2025)
Open Access | Times Cited: 8
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He, Zi Hui, Li Xu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113946-113946
Closed Access | Times Cited: 58
Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells
Joshua P. Smalley, India M. Baker, Wiktoria A. Pytel, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 7, pp. 5642-5659
Open Access | Times Cited: 56
PROTAC degraders as chemical probes for studying target biology and target validation
Václav Nêmec, Martin P. Schwalm, Susanne Müller, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7971-7993
Closed Access | Times Cited: 55
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity
Laura Sinatra, Jing Yang, Julian Schliehe‐Diecks, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16860-16878
Open Access | Times Cited: 42
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Jiranan Chotitumnavee, Yasunobu Yamashita, Yukari Takahashi, et al.
Chemical Communications (2022) Vol. 58, Iss. 29, pp. 4635-4638
Closed Access | Times Cited: 40
Targeted protein degradation in cancers: Orthodox PROTACs and beyond
Jin Li, Xinxin Chen, Aiping Lü, et al.
The Innovation (2023) Vol. 4, Iss. 3, pp. 100413-100413
Open Access | Times Cited: 36
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 28
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 27
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates
Hai‐Tsang Huang, Ryan J. Lumpkin, Ryan W. Tsai, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1227-1236
Closed Access | Times Cited: 16
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 15
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
Digant Nayak, Dongwen Lv, Yaxia Yuan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
Felix Feller, Irina Honin, Martina Miranda, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation
Donghuan Sun, Jing Zhang, Guoqiang Dong, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14276-14288
Closed Access | Times Cited: 38
Machine Learning Modeling of Protein-Intrinsic Features Predicts Tractability of Targeted Protein Degradation
Wubing Zhang, Shourya S. Roy Burman, Jiaye Chen, et al.
Genomics Proteomics & Bioinformatics (2022) Vol. 20, Iss. 5, pp. 882-898
Open Access | Times Cited: 31
Development of the first non-hydroxamate selective HDAC6 degraders
Tim Keuler, Beate König, Nico Bückreiß, et al.
Chemical Communications (2022) Vol. 58, Iss. 79, pp. 11087-11090
Closed Access | Times Cited: 29
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities
Yuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 8, pp. 1160-1171
Open Access | Times Cited: 17
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout
Raphael R. Steimbach, Corey J. Herbst‐Gervasoni, Severin Lechner, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 41, pp. 18861-18875
Open Access | Times Cited: 27
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology
Natsuko Macabuag, William Esmieu, Perla Breccia, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12445-12459
Open Access | Times Cited: 23
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation
Yufeng Xiao, Seth Hale, Nikee Awasthee, et al.
Cell chemical biology (2023) Vol. 30, Iss. 11, pp. 1421-1435.e12
Open Access | Times Cited: 14
Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics
Kheewoong Baek, Rebecca J. Metivier, Shourya S. Roy Burman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top